OBJECTIVES: To examine the hypothesis that a sustained rise in plasma acylation stimulating protein (ASP, C3a desarg) accompanies the elevation in triacylglycerol that follows the ingestion of an oral fat load. DESIGN: Following an overnight fast, blood samples were obtained from healthy volunteers while fasting and 15 min, 1, 2, 4, 6 and 8 h following ingestion of: (i) a liquid meal, rich in dairy fat (eight subjects) and (ii) a semi-liquid meal, with higher total fat content and rich in polyunsaturated fat (six subjects). SUBJECTS AND METHODS: Four male and four female volunteers (age range: 22 ± 51 y; body mass index (BMI): 17.9 ± 26.9 kgam 2 ) received the ®rst meal. Six subjects (age range: 32 ± 60 y; BMI: 18.0 ± 28.4 kgam 2 ), including three from the ®rst study, received the second meal using the same protocol. ASP and C5a were measured by radioimmunoassay (RIA) and the complement proteins C3, factor B and C5 by radial immunodiffusion or nephelometry. Tumour necrosis factor (TNF)-a was measured by enhanced ELISA, and plasma cholesterol and triacylglycerol by an automated enzymatic method. The presence of chylomicrons was assessed in post-prandial plasma samples taken after the second meal. RESULTS: There was no signi®cant change in mean ASP concentration in either group at any time point, following ingestion of either meal. However, there was a signi®cant positive linear trend in ASP following the second fat challenge (ANOVA; P`0.05). There was also no change in complement proteins, plasma cholesterol or TNF-a. Plasma triacylglycerol rose signi®cantly after the ®rst and second meals (P`0.05 and P`0.001 at 2 h post-prandially); the mean maximum rise above the fasting level was 58 AE 41% and 89 AE 38% respectively (mean AE s.d.). Chylomicrons were detected in samples taken from each subject after the second meal. Analysis of individual ASP data showed a sustained rise in one subject after the ®rst meal and two subjects after the second meal. Substantial variation in ASP concentration was observed in samples taken in the ®rst 2 h post-prandially. CONCLUSION: There was no signi®cant change in ASP nor other complement proteins for either group of subjects following ingestion of the lipid loads. Individual data showed substantial variation in post-prandial ASP, but multiple plasma sampling did not de®ne the basis for this variation.
Introduction
Murine and human adipocytes synthesise and secrete proteins of the alternative complement pathway. 1, 2 Studies of fat cells in vitro suggest that the function of this pathway is important in the regulation of triacylglycerol formation and glucose transport. 3 Speci®cally, the C3 cleavage product, C3a desarg has been shown to be a regulator of these metabolic processes. This molecule, also termed acylation stimulating protein (ASP), increases the activity of diacylglycerol acyltransferase, 4 the action of which is impaired in ®broblasts obtained from subjects with hyperapobetalipoproteinaemia. 5 The effect of ASP on glucose transport is separate although additive to that of insulin and involves translocation of glucose transporters to the external membrane of the adipocyte. 3 Work by Maslowska et al 6 shows that the generation of ASP in vitro, is dependent on interaction between a component(s) of chylomicrons and the fat cell membrane.
Choy et al 1 have demonstrated impaired alternative pathway activation in explanted adipose tissue and cultured adipocytes, derived from rodent models of obesity. They attributed this defect to a signi®cant reduction in adipsin, the mouse homologue of human complement factor D, which is essential to the ®rst catalytic step of alternative pathway activation. Such a defect would reduce cleavage of native C3 and ASP formation; this led the authors to postulate that factor D de®ciency could affect fat cell metabolism. Other alternative pathway factors (that is, C3 and factor B) were present in normal amounts in these obese animals, the latter being highly responsive to tumour necrosis factor (TNF)-a. We have shown a similar (10-fold) rise in factor B in response to TNF-a in cultured mouse 3T3 cells. 2 Cian¯one et al 7 examined the effect of an oral fat load on plasma ASP levels in samples taken from healthy human subjects over an 8 h period. They reported a sustained rise in plasma concentration, which coincided with elevated plasma triacylglycerol levels and proposed that this change could affect fat cell function. However, the plasma ASP concentrations reported in that study were approximately 500-fold greater than those described by other workers in normal subjects and during states of pathological complement activation. With recognition that complement behaviour may in¯uence fat cell function and post-prandial lipid metabolism (see Refs 8 and 9, for review), we performed a similar study in eight healthy subjects. ASP and the native complement proteins C3 and factor B of the alternative pathway and C5a and C5 of the terminal complement complex were examined in the fasting state and following the ingestion of a high fat liquid meal. Post-prandial samples were obtained at 15 min, 1, 2, 4, 6 and 8 h. Plasma cholesterol and triacylglycerol were measured on the fasting sample and at 1, 2, 4, 6 and 8 h following ingestion of the fat load. To further clarify post-prandial changes in plasma ASP and triacylglycerol, six volunteers, (including three from the ®rst study) received a second lipid challenge with a high polyunsaturated lipid content, to maximise chylomicron formation and plasma triacylglycerol response.
Subjects and methods
Eight healthy laboratory and medical staff (four male and four female; age: 22±51 y) received a standardised lipid-rich liquid meal, following a 12 h fast. They were allowed unlimited access to water and tea and coffee without additives during the experiment. Their clinical characteristics are shown in Table 1 . All were well at the time of the study and were not taking treatment likely to in¯uence lipid or complement behaviour. Body weight, height and waist and hip circumferences were measured for each subject at the conclusion of the study. Waist circumference was examined at the narrowest point between the costal margin and pelvic brim and hip circumference at the level of greatest gluteal protuberance.
Analysis of fat loads
Each of the eight subjects received an initial fat load, which consisted of whole milk (250 g), pure cream (165 g), vanilla ice cream (50 g) and a commercial low-joule chocolate¯avouring (80 g). These constituents were contained in a total volume of 720 ml, the nutrient composition of which was fat: 75 g, carbohydrates: 25 g and protein: 14 g. Subjects received 8 mlakg, the constituents being mixed immediately before consumption and drunk over a 5 min period between 08.30±08.45 h. The meal was well tolerated. Blood samples were collected 10 min before consumption and 15 min, 1, 2, 4, 6 and 8 h post-prandially (subject JW did not donate an 8 h sample) for measurement of: (i) C3, factor B and C5 and the activation products, ASP and C5a, (ii) TNF-a and (iii) plasma cholesterol and triacylglycerol.
In a second experiment, six subjects (including three involved in the initial experiment) received a fat load designed to maximise the post-prandial triacylglycerol response. Each subject received a mixture of yoghurt, cream, soya bean oil and gelatine, avoured with raspberries in syrup and made to a volume of 400 ml. The nutritional analysis of each serving (400 g) was fat: 100 g, carbohydrates: 39 g and protein: 10.5 g. Each serving contained 50 ml of soya bean oil. The protocol for these additional experiments was identical to the initial study: each subject consumed the meal over 5±10 min between 08.30± 08.45 h, with samples taken prior to ingestion and at 15 min, 1, 2, 4, 6 and 8 h, thereafter.
Measurement of ASP and complement proteins
ASP was measured by a radioimmunoassay (RIA) (Biotrak, Amersham, Buckinghamshire, UK), which used a rabbit anti-C3a desarg antibody and 5 preprepared standard samples (C3a desarg concentration: 1, 2.5, 5, 10 and 25 nga50 uL). Each measurement was performed in duplicate on the pre-ingestion sample and all six samples obtained after the fat meal. Depending on peptide concentration, the intra-assay coef®cient of variation (CV) was 3±9% and the inter- assay CV was 16.5±20.5%, with values being lower in the upper half of the normal range. To minimise interassay variation, ®rst meal samples from six subjects were measured in one assay, while the remainder were measured in a second assay. All second meal samples were tested in the same assay. Native complement proteins (above) were measured on serum samples using either radial immunodiffusion (that is, factor B and C5) or nephelometry (C3). The intra-and inter-assay CV for these assays were as follows: C3, 3.2% and 5.7%; factor B, 3.5% and 12.5%; C5, 3.5% and 10%, respectively. C5a was measured by RIA (Biotrak, Amersham, Buckinghamshire, UK).
Measurement of TNF-a and lipids
TNF-a was measured by an enhanced ELISA (Amersham). Assays were performed on the same timed plasma samples as those used for quantitation of ASP. Plasma cholesterol and triacylglycerol were measured by an automated enzymatic method in a major clinical chemistry department. Chylomicrons were detected in post-prandial samples, taken after the second meal, by agarose gel electrophoresis, followed by ®xation in methanol and staining with Fat Red 7B.
Statistical analysis
Data for ASP, complement proteins, TNF-a and plasma lipids were expressed as the Mean AE s.d. Analysis of differences between fasting and postprandial values was performed by repeated-measures ANOVAs for parametric and non-parametric data. The difference between fasting and maximum postprandial triacylglycerol concentrations was also analysed by a paired Student's`t' test. Body mass index (BMI) was calculated as weight (kg)aheight (m) 2 . The relationship between plasma ASP and native C3 concentration was examined by linear regression analysis with calculation of the coef®cient,`r'. The relationship between fasting and maximum levels of ASP and area under the curve (AUC) for plasma triacylglycerol concentration (that is, post prandially), was also examined by correlation analysis.
Results
Fasting and post-prandial plasma ASP concentration ASP concentrations following the ®rst fat meal are shown in Table 2 and Figure 1 . There was no signi®cant change in mean concentration at any time-point following ingestion, compared to fasting values (ANOVA: P b 0.05), although several subjects showed minor increases and decreases at points 164  134  142  138  160  152  148  ML  112  110  110  132  124  138  120  TT  140  160  140  160  240  200  210  BP  180  154  126  132  126  128  140  SO  204  132  138  150  124  136  124  MM  114  106  122  130  130  132  126  LP  134  172  136  140  138  120  126  JW  126  124  114  116  130 following the challenge. Only subject TT showed elevation of plasma ASP in consecutive samples taken at 4, 6 and 8 h post-prandially (that is, 71%, 43% and 50%), respectively, above the fasting level.
Following the second meal, there was no signi®cant change in mean ASP level at any time-point postprandially for the group of six volunteers (ANOVA) (see Table 3 and Figure 1 ). However, in contrast to post-prandial data with the ®rst meal, there was a signi®cant positive linear trend in ASP concentration following the second challenge (ANOVA: P`0.05).
Variation in the post-prandial ASP pattern of individual subjects is discussed below.
There was no signi®cant change in plasma C3, B or C5 concentration during the post-prandial period following either meal. Similarly, C5a remained 10 ngaml (that is, below assay detectability) in all subjects. There was no relationship between C3 and ASP levels, either fasting or at the time of maximum post-prandial ASP concentration.
Fasting and post-prandial plasma lipids
The mean fasting plasma cholesterol in subjects undertaking the ®rst meal was 5.7 mmolaL (range: 3.7±7.9) and 5.6 mmolaL (range: 4.5±6.8) in those undertaking the second. No subject showed a signi®-cant change in plasma cholesterol in any sample, with all values remaining within 10% of the fasting level. Plasma triacylglycerol rose in all subjects and there were signi®cant differences between fasting levels and maximum post-prandial concentrations (®rst meal: P`0.05 at 2 h; second meal: P`0.001 at 2 h and P`0.01 at 4 h; paired`t' test). These data are shown in Table 4 and Table 5 . The mean maximum increase following the ®rst meal was 58 AE 41% of the fasting value and 89 AE 38% following the second meal. Chylomicrons were detected in the 2, 4 and 8 h samples taken from each subject after the second meal. There was no change in plasma cholesterol or triacylglycerol in any 15 min sample collected after this meal. There was no correlation between fasting or maximum post-prandial ASP concentrations and areas under the triacylglycerol curve between 0±8 h (P b 0.05). The mean fasting plasma ASP concentration in subjects with normal fasting triacylglycerol levels (that is, 1.7 mmolaL) was no different to that of subjects with elevated levels : 140 ngamL and 136 ngamL, respectively.
Patterns of post-prandial change in plasma ASP and triacylglycerol There were differences in the ASPatriacylglycerol response among individuals ingesting the ®rst and second meals, and including those three subjects that underwent both challenges (see Tables and Figure 2 ). Based on intra-and inter-assay coef®cients of variation, a signi®cant sustained change in ASP was de®ned as ! 20% rise in concentration above the fasting level in two or more consecutive post-prandial samples, excluding the 15 min and 1 h collections. Using these criteria, only subject TT showed a signi®cant change in ASP following the ®rst meal (see above). Subjects SO and BP (®rst meal) showed a signi®cant decline in ASP at 15 min and 1 h postprandially (that is, 35% and 30% below fasting level) with no subsequent return to the fasting level. Data for SO are shown in Figure 2 .
Following the second lipid meal, several patterns of ASP response were observed. These data are shown in Table 3 and Figure 2 . Subjects BP and XW (fasting triacylglycerol: 1.9 mmolaL and 0.9 mmolaL, respectively) showed a signi®cant rise in ASP in three and four post-prandial samples, respectively. Subjects SO and GJ showed a biphasic response with an early fall in plasma concentration, followed by a rise which, in the case of SO, exceeded the fasting value by 35%. However, neither of these subjects showed a sustained rise in ASP in consecutive samples. Subject TT showed a pattern similar to that observed following consumption of the ®rst lipid challenge.
TNF-a concentration
Following the ®rst meal, plasma TNF-a remained below assay detectability (that is,`0.1 pgaml) in seven subjects, while subject JW reached a maximum of 0.6 pgaml (normal). TNF-a could not be detected in any subject following consumption of the second meal.
Anthropometric measurements
BMI, waistahip ratio (WHR) and waist circumference are shown in Table 1 . There was no relationship between any of these indices and fasting or maximum post-prandial ASP concentration. 
Discussion
In-vitro data support the concept that ASP plays a role in the stimulation of triacylglycerol synthesis in human adipocytes. Moreover, chylomicrons contained in post-prandial plasma have been shown to selectively increase ASP production in a time-and concentration-dependent manner. 6 In support of these observations, Cian¯one et al 7 have reported a sustained rise in ASP following an oral fat load in normolipaemic human volunteers. However, we were unable to demonstrate such a change in the majority of subjects following the ingestion of meals rich in dairy and polyunsaturated fats. Most showed minor variations (that is,`20% fasting value) in concentration at isolated time-points, but these did not necessarily alter the post-prandial ASP pattern. With the ®rst (dairy-rich) meal, only subject TT showed a rise in ASP comparable to that reported by Cian¯one et al 7 ; this meal contained less fat than that used previously 7 or contained in our second challenge. Following the second meal, only two of six subjects showed a sustained ASP response.
The fasting and maximum ASP concentrations also differed signi®cantly from those observed by Cianone et al. They found a peak level of 12.6 AE 4.9 mgadL and have reported similar values in other studies. 10, 11 By contrast, we found maximum post-prandial levels that were approximately 500-fold less than this value. This difference raises questions about the respective methods of quantitation of ASP. Other workers report values that coincide closely with those quoted in our study. Belmont et al, 12 for example, observed levels of 134AE 11 ngamL (mean AE s.e.m.) in healthy subjects and 526AE 63 ngamL in acutely ill patients with active systemic lupus erythematosus (SLE). Similarly, Porcel et al 13 reported a maximum concentration of 267 ngaml in healthy subjects and 590 ngamL in patients with acute lupus. In patients undergoing haemodialysis, Chenoweth et al 14 noted a range of 115±867 ngaml in patients dialysed against a cuprophane membrane. Although more recent studies by Cian¯one report the use of the same RIA 15 used in our study, the outcome of their original oral fat challenge is still cited as in-vivo evidence to support their in-vitro ®ndings. 9 One explanation for the unphysiologically high levels of ASP would be the simultaneous measurement of native C3 through the use of a polyclonal antibody; this native molecule is in much higher concentration in plasma, that is, approximately 0.6-1.3 mgamL. This simultaneous measurement can occur if no speci®c C3 precipitation step is included in the assay. ASP may also be generated from C3 during storage in vitro, although this would be unlikely to produce such a major change in plasma concentration.
Our studies suggest that the plasma ASPatriacylglycerol response following a fat challenge is not uniform, even among normolipaemic subjects. For example, the ®rst (lesser) fat challenge was undertaken by eight subjects, ®ve of whom had normal fasting cholesterol and triacylglycerol concentrations. Of this subgroup, only one (that is, subject TT) showed a signi®cant rise in ASP post-prandially. Following the second fat meal, two of four subjects with normal or minimally elevated triacylglycerol concentration showed a signi®cant increase in ASP, while the other two showed no signi®cant change. Despite a mean maximum increase in triacylglycerol of 88% after this second meal, only these two subjects showed a sustained rise in ASP. However, all six subjects showed a rise of ! 20% in single postprandial samples. The interpretation of this ®nding is uncertain and it is possible that these isolated changes re¯ect more sustained periods of ASP elevation that were not detected by the sampling protocol.
The second lipid challenge used a greater total amount of fat and of polyunsaturates to maximise the triacylglycerol response and hence amplify the post-prandial ASP response. Maslowska's work 6 suggests that this meal would enhance chylomicron formation and subsequent activation of secreted C3 in the vicinity of the adipocyte. Sampling from the plasma compartment provides only an indirect measurement of this extra-vascular ASP formation. Moreover, it would seem unlikely that changes in C3 metabolic behaviour would be observed within 15 min of ingestion of the fat meal. There have been no studies of the compartmental distribution of C3a desarg (ASP) following complement activation in vivo. However, several studies document the distribution of other complement proteins, including native C3, and show that ! 30% of molecules reside outside the intravascular compartment under normal conditions. This percentage may increase following complement activation, 16 thus providing the potential for signi®cant interchange between intra-and extra-vascular compartments in response to speci®c stimuli. Hence, it is possible that variation in 15 min and 1 h samples re¯ects changes in compartmental distribution rather than true change in metabolic behaviour.
TNF-a has been shown to induce ASP production in culture by increasing factor B synthesis and hence turnover of the intracellular alternative complement pathway. 1 It has also been shown that depletion of this cytokine in a rat hepatoma model increases lipoprotein lipase activity in white adipose tissue, with a corresponding reduction in circulating triacylglycerol levels. 17 However, we could not demonstrate a change in plasma TNF-a concentration following either lipid challenge.
One explanation for the failure to demonstrate a signi®cant change in ASP concentration following the ®rst challenge was the difference in lipid content between this meal and that used by Cian¯one and coworkers. 7 This would be important if chylomicron formation is required for C3 activation. While the second fat challenge produced some differences in post-prandial behaviour, this response was not observed consistently; hence, the physiological signi®cance of the phenomenon remains in question. Nevertheless, the studies of ASP behaviour in vitro emphasise the need for further examination of this molecule in relation to fat cell behaviour.
